vs

Side-by-side financial comparison of PEDEVCO CORP (PED) and Simulations Plus, Inc. (SLP). Click either name above to swap in a different company.

PEDEVCO CORP is the larger business by last-quarter revenue ($23.1M vs $18.4M, roughly 1.3× Simulations Plus, Inc.). Simulations Plus, Inc. runs the higher net margin — 3.7% vs -36.8%, a 40.5% gap on every dollar of revenue. On growth, PEDEVCO CORP posted the faster year-over-year revenue change (118.2% vs -2.7%). Over the past eight quarters, PEDEVCO CORP's revenue compounded faster (68.6% CAGR vs 0.3%).

PEDEVCO Corp is an independent energy company specializing in the acquisition, exploration, development, and production of oil and natural gas assets. It primarily holds and operates onshore resource properties across continental US basins, serving domestic wholesale, utility, and industrial energy customer segments.

Simulations Plus, Inc. develops absorption, distribution, metabolism, excretion, and toxicity (ADMET) modeling and simulation software for the pharmaceutical and biotechnology, industrial chemicals, cosmetics, food ingredients, and herbicide industries. In September 2014, the company acquired Cognigen Corporation, a provider of clinical trial data analysis and consulting services.

PED vs SLP — Head-to-Head

Bigger by revenue
PED
PED
1.3× larger
PED
$23.1M
$18.4M
SLP
Growing faster (revenue YoY)
PED
PED
+120.9% gap
PED
118.2%
-2.7%
SLP
Higher net margin
SLP
SLP
40.5% more per $
SLP
3.7%
-36.8%
PED
Faster 2-yr revenue CAGR
PED
PED
Annualised
PED
68.6%
0.3%
SLP

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
PED
PED
SLP
SLP
Revenue
$23.1M
$18.4M
Net Profit
$-8.5M
$676.0K
Gross Margin
59.1%
Operating Margin
-21.3%
3.9%
Net Margin
-36.8%
3.7%
Revenue YoY
118.2%
-2.7%
Net Profit YoY
-243.5%
228.2%
EPS (diluted)
$-2.23
$0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PED
PED
SLP
SLP
Q4 25
$23.1M
$18.4M
Q3 25
$7.0M
$17.5M
Q2 25
$7.0M
$20.4M
Q1 25
$8.7M
$22.4M
Q4 24
$10.6M
$18.9M
Q3 24
$9.1M
$18.7M
Q2 24
$11.8M
$18.5M
Q1 24
$8.1M
$18.3M
Net Profit
PED
PED
SLP
SLP
Q4 25
$-8.5M
$676.0K
Q3 25
$-325.0K
$-681.0K
Q2 25
$-1.7M
$-67.3M
Q1 25
$140.0K
$3.1M
Q4 24
$5.9M
$206.0K
Q3 24
$2.9M
$843.0K
Q2 24
$2.7M
$3.1M
Q1 24
$773.0K
$4.0M
Gross Margin
PED
PED
SLP
SLP
Q4 25
59.1%
Q3 25
56.4%
Q2 25
64.0%
Q1 25
58.5%
Q4 24
54.0%
Q3 24
36.6%
Q2 24
71.5%
Q1 24
72.2%
Operating Margin
PED
PED
SLP
SLP
Q4 25
-21.3%
3.9%
Q3 25
-12.0%
3.8%
Q2 25
-32.2%
-364.5%
Q1 25
1.7%
12.1%
Q4 24
-12.9%
0.7%
Q3 24
31.3%
-6.2%
Q2 24
22.3%
10.1%
Q1 24
7.6%
24.3%
Net Margin
PED
PED
SLP
SLP
Q4 25
-36.8%
3.7%
Q3 25
-4.7%
-3.9%
Q2 25
-24.0%
-330.6%
Q1 25
1.6%
13.7%
Q4 24
56.0%
1.1%
Q3 24
32.2%
4.5%
Q2 24
22.7%
16.9%
Q1 24
9.5%
22.0%
EPS (diluted)
PED
PED
SLP
SLP
Q4 25
$-2.23
$0.03
Q3 25
$0.00
$-0.03
Q2 25
$-0.02
$-3.35
Q1 25
$0.00
$0.15
Q4 24
$2.69
$0.01
Q3 24
$0.03
$0.04
Q2 24
$0.03
$0.15
Q1 24
$0.01
$0.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PED
PED
SLP
SLP
Cash + ST InvestmentsLiquidity on hand
$3.2M
$35.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$207.4M
$127.1M
Total Assets
$375.9M
$137.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PED
PED
SLP
SLP
Q4 25
$3.2M
$35.7M
Q3 25
$10.9M
$32.4M
Q2 25
$8.5M
$28.4M
Q1 25
$10.4M
$21.4M
Q4 24
$4.0M
$18.2M
Q3 24
$4.6M
$20.3M
Q2 24
$6.1M
$119.0M
Q1 24
$13.3M
$108.5M
Stockholders' Equity
PED
PED
SLP
SLP
Q4 25
$207.4M
$127.1M
Q3 25
$115.4M
$124.8M
Q2 25
$115.2M
$123.8M
Q1 25
$116.2M
$189.5M
Q4 24
$115.6M
$184.7M
Q3 24
$106.5M
$182.4M
Q2 24
$103.2M
$180.9M
Q1 24
$100.0M
$177.0M
Total Assets
PED
PED
SLP
SLP
Q4 25
$375.9M
$137.8M
Q3 25
$135.9M
$131.9M
Q2 25
$136.8M
$134.4M
Q1 25
$145.6M
$201.4M
Q4 24
$128.3M
$196.9M
Q3 24
$114.3M
$196.6M
Q2 24
$111.0M
$192.7M
Q1 24
$118.3M
$194.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PED
PED
SLP
SLP
Operating Cash FlowLast quarter
$-2.1M
$4.2M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
6.26×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PED
PED
SLP
SLP
Q4 25
$-2.1M
$4.2M
Q3 25
$7.4M
$5.6M
Q2 25
$-420.0K
$8.1M
Q1 25
$5.9M
$5.7M
Q4 24
$4.2M
$-1.3M
Q3 24
$8.3M
$1.7M
Q2 24
$4.6M
$5.7M
Q1 24
$-4.3M
$5.8M
Free Cash Flow
PED
PED
SLP
SLP
Q4 25
Q3 25
$5.3M
Q2 25
$7.8M
Q1 25
$5.6M
Q4 24
$-1.4M
Q3 24
$1.6M
Q2 24
$5.6M
Q1 24
$5.4M
FCF Margin
PED
PED
SLP
SLP
Q4 25
Q3 25
30.5%
Q2 25
38.5%
Q1 25
25.0%
Q4 24
-7.2%
Q3 24
8.8%
Q2 24
30.0%
Q1 24
29.4%
Capex Intensity
PED
PED
SLP
SLP
Q4 25
0.0%
Q3 25
1.5%
Q2 25
1.5%
Q1 25
0.3%
Q4 24
0.5%
Q3 24
0.1%
Q2 24
0.6%
Q1 24
2.4%
Cash Conversion
PED
PED
SLP
SLP
Q4 25
6.26×
Q3 25
Q2 25
Q1 25
42.34×
1.84×
Q4 24
0.71×
-6.18×
Q3 24
2.83×
1.97×
Q2 24
1.71×
1.81×
Q1 24
-5.56×
1.44×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PED
PED

Segment breakdown not available.

SLP
SLP

Services Segment$9.5M52%
Development$7.2M39%
Discovery$1.3M7%

Related Comparisons